The P2 outer membrane protein of Haemophifus influenzue belongs to a class of apparently ubiquitous proteins in Gram-negative bacteria that function as porins. Murine hybridomas raised to the P2 protein and synthetic peptides were used to investigate the structural and antigenic relationships among P2 proteins of encapsulated and nonencapsulated H. influenzae. Three monoclonal antibodies (mAbs), P2-17, P2-18 and P2-19, recognizing epitopes on the P2 protein, as shown by Western immunoblotting of outer membrane preparations, and purified and recombinant P2 proteins are described. The epitopes reactive with the mAbs were widely distributed among H. influenzae strains since 70-100% of strains of encapsulated and non-encapsulated isolates collected worldwide were recognized by individual mAbs. None of the mAbs reacted with H. parainpuenzae or other bacterial species. The peptide composition of P2 epitopes was determined by analysis of mAb reactivity with a series of overlapping synthetic peptides that covered the amino acid sequences of H. influenzae type b. The domains recognized by these mAbs were completely distinct. mAb P2-18, reactive with an epitope conserved among all H. inpUenzue P2 poM molecules which were screened, recognized a peptide corresponding to the N-terminal segment (residues 1-14) . The P2-17-and P2-19-specific epitopes were located between residues 28 and 55, and 101 and 129, respectively. None of the epitopes were exposed on the cell surface since no mAbs bound to intact live bacteria. The identification of epitopes that are shared among P2 proteins from different strains of encapsulated and non-encapsulated H. influenzae strains suggests that the P2 porin protein from all H. influenzae strains has been highly conserved and that these epitopes may represent amino acid residues critical to the p o M ' s structure. 0001-7059 O 1992 SGM Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11 On: Fri, 28 Dec 2018 16:37:34 162 J . Hamel and others Downloaded from www.microbiologyresearch.org by
Introduction
Haemophilus influenzae is responsible for a variety of diseases in humans, ranging from chronic respiratory infection to meningitis. Virtually all cases of meningitis and other forms of invasive infection are caused by organisms that possess a serotype b capsule (Turk, 1984) . Although strains expressing other capsule types or lacking a capsule are usually associated with superficial infections or asymptomatic carriage, these strains have now been recognized as important invasive pathogens in some human populations (Greene, 1978; Gratten et al., 1985; Munson et al., 19896; Weinberg et al., 1989) . This has been particularly well documented in Pakistan where Author for correspondence. Tel. (61 3) 957 01 79; fax (61 3) 952 7767. Abbreviations: mAb, monoclonal antibody. bacteremic cases of lower respiratory tract infection were shown to be caused by non-encapsulated strains (Weinberg et al., 1989) . For many years it has been known that encapsulated strains frequently lose the ability to synthesize a capsule (Pittman, 1931; Hoiseth et al., 1985) . Recently, however, Musser et al. (1986) demonstrated conclusively that most non-encapsulated clinical isolates are genetically unrelated to the type b strains and are not phenotypic variants of encapsulated isolates that have recently lost the polysaccharide capsule. These findings emphasize the need for a new vaccine capable of protecting against a wide range of H. injluenzae strains, both encapsulated and non-encapsulated, and suggest that a vaccine may require the inclusion of non-capsular antigens.
Several outer membrane proteins are currently being considered as potential vaccine candidates since they have induced antibodies protective in an animal model of infection (Munson et al., 1983;  Kimura et a/., 1985; Munson & Granoff, 1985;  Granoff & Munson, 1986; Green et al., 1987;  Loeb, 1987; Deich et al., 1990 ; Thomas et al., 1990) . One of these proteins, P2, has porin activity (Vachon et al., 1985) . Porins belong to a class of apparently ubiquitous proteins which form water-filled channels across the outer membrane and have remarkably conserved physical properties (Nikaido & Vaara, 1985) . In addition to its porin activity, P2 protein may play an important role in the pathogenesis of H . injluenzae infection, since the absence of its expression drastically reduced the ability of H . injluenzae type b to grow in vitro, and to produce bacteremia in an animal model (Cope et al., 1990) . A major step in the understanding of H . injluenzae P2 protein was achieved by the recent cloning of the structural gene (Hansen et al., 1988 ; Munson & Tolan, 1989) . Comparative analysis of the nucleotide and amino acid sequences of four different type b strains indicated that the P2 genes were highly conserved (Munson et al., 1989a) . This observation was substantiated by the isolation of P2-specific monoclonal antibodies (mAbs) reactive with a large panel of H . injluenzae type b isolates (Hamel et al., 1987a, b ; Hansen et al., 1989; Martin et al., 1990) . Moreover, recent immunological studies on the epitope mapping of P2 protein from H. injluenzae type b have revealed the presence of at least four highly conserved regions (Martin et al., 1991) .
In contrast to the type b strains, the P2 protein in nontypable H . injluenzae seems to exhibit considerable variation. The molecular mass of P2 protein is more variable among non-typable strains than among type b strains (Loeb & Smith, 1980; Barenkamp et al., 1981 Barenkamp et al., , 1982 Murphy et al., 1983) . Several studies have suggested that many of the antigenic differences among non-typable strains reside in the P2 molecule (Murphy & Bartos, 1988 a, b ; Groeneveld et al., 1989 ; van Alphen et al., 1991 ; Haase et al., 1991) . Further antigenic analysis of P2 protein may provide information relevant to future vaccine development, and to further definition of structure-function relationships. In this paper, we studied the antigenic relationship between P2 proteins by use of mAbs and synthetic peptides. We report the identification and localization of three conserved epitopes among the P2 porin proteins from encapsulated and non-encapsulated H . injluenzae strains. t A dot enzyme immunoassay described in Methods was used for the screening of mAbs against bacterial strains. $ Multilocus enzyme electrophoretic analysis was used to determine the genetic relatedness among bacterial isolates. The characterization of encapsulated strains of H. injluenzae was performed by J. M. Musser as described elsewhere . Clonally restricted nontypable isolates recovered from Islamabad, Pakistan, were characterized by Weinberg et al. (1989) .
Methods

Bacterialstrains
isolates of serotype b, 4 isolates of serotype a and 2 isolates of serotype d. The non-typable isolates were cultured from asymptomatic carriers, patients with superficial infections or patients with invasive disease. Of the non-typable invasive strains, one was recovered in Canada, one in the United States, one in Papua New Guinea and two in Sweden; the H . intuenzae P2 porin protein 163 last five were representatives of the most common non-typable clonal groups from the Pakistan study (Weinberg et al., 1989) . Encapsulated H. influenzae are clonally diverse, as analysed by their outer membrane protein profile (Barenkamp et al., 1981) and by multilocus enzyme electrophoresis (Musser et al., 1988 . Representatives of the most prevalent clones were studied. H. influenzae serotype b isolates included prototype strains MinnA (OMP 1 H), Durst (OMP 2L), 161 3 (OMP 3L), WHAEM294 (OMP 6U), and strains KIL7 and WAR28, both from divergent clones assigned to primary phylogenetic division I1 
Antigen preparations. Various H . influenzae antigens were prepared for immunization and immunoassays. The extraction of outer membranes from all H. influenzae isolates was performed by the lithium chloride method as described previously (Hamel et al., 1987~) . Sarcosyl-insoluble preparations enriched in the major outer membrane proteins from non-typable H. influenzae MTL6 were prepared by the method described by Barenkamp et al. (1981) . The P2 protein from non-typable H. influenzae 12085 was isolated according Munson et al. (1983) . P2 protein purified from H. influenzae type b MinnA and the sarcosyl-insoluble fraction from recombinant E. coli JM 101(pRSM478), which expressed the P2 from MinnA, were generously provided by R. S. Munson (Munson et al., 1983; Munson & Tolan, 1989) .
Production of mAbs.
Balb/c mice were immunized intraperitoneally with 20 pg sarcosyl-insoluble proteins of non-typable H. influenzae MTL6 suspended in Freund's complete adjuvant. Two weeks later, the mice were given another injection of Freund's incomplete adjuvant. Three days before the fusion, the mice were boosted with 1Opg P2 protein from non-typable H. influenzae 12085. Hybridomas were produced by fusion of splenic lymphocytes from immunized mice with non-secreting Sp2/0 myeloma cells as previously described (Hamel et al., 1987~) . P2-protein-specific hybridomas were cloned by sequential limiting dilutions, expanded and frozen in liquid nitrogen. The class, subclass and light-chain type of each mAb was determined by ELISA as described previously (Martin et al., 1990) . Preliminary characterization of mAb P2-17 has been reported previously (Martin et al., 1990) .
Peptide synthesis. The complete nucleotide and derived amino acid sequences of the P2 protein of H. influenzae type b MinnA have been published (Munson & Tolan, 1989) . A series of 17 overlapping peptides (12-30 amino acid residues each) covering the entire P2 protein sequence were synthesized as previously described (Martinet al., 1991) . The sequence and the position of all peptides synthesized are shown in Fig. 1 .
SDS-PAGE and Western immunoblotting.
Outer membrane proteins were resolved by electrophoresis on homogeneous 12.5% polyacryl-
amide gels using the PhastSystem (Pharmacia). After separation, the proteins were stained with Coomassie blue or transferred from the gel to a nitrocellulose membrane (Bio-Rad) using the PhastTransfer Semidry Transfer Kit (Pharmacia). Luminescent detection of antigens reactive with the mAbs was performed by an indirect antibody immunoassay using peroxidase-labelled anti-mouse immunoglobulins and the luciferin-enhanced substrate (Proulx et al., 1991) . The blot was exposed for 5 min at room temperature to Kodak XAR-5 film in a Kodak X-omatic cassette fitted with intensifying screens. The following proteins (Sigma) were used as molecular mass standards : bovine serum albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (29 kDa), soybean trypsin inhibitor (20.1 kDa), and alactalbumin (14.2 kDa).
Enzyme immunoassay procedures. The ELISA procedure, using outer membrane preparations from H. influenzae as coating antigens, was performed as detailed previously (Hamel et al., 19870) . The peptide ELISA (Martin et al., 1991) was carried out by coating synthetic peptides onto microtitration plates (Maxisorp immunoplate; Nunc) at a concentration of 5pg ml-l in 50m~-sodium carbonate buffer, pH 9.6. A peptide inhibition assay was done using plates coated with outer membrane preparations (Martin et al., 1991) .
A dot enzyme immunoassay (Martin et al., 1991) was used for the rapid screening of mAbs against a large number of bacterial strains. Briefly, bacteria were suspended in PBS (0.9% NaCl; 10 mM-potassium phosphate buffer, pH 7.4) with or without 2% (v/v) SDS, boiled for 5 min, and then filtered through a nitrocellulose membrane by gravity using the Bio-Dot microfiltration apparatus (Bio-Rad). The membrane was blocked by incubation with PBS containing 3% (w/v) skimmed milk. This was followed by incubation with culture supernatants containing the mAbs. Identification of the strains reactive with the mAbs was then achieved using peroxidase-labelled anti-mouse immunoglobulins as secondary antibody.
Antibody accessibility radwimmunoassay. Absorption of mAbs at the surface of live bacteria was performed (Martin et al., 1988; Proulx et al., 1991) in order to determine whether mAbs were directed against surface exposed epitopes. Briefly, hybridoma culture supernatant was mixed with lo9 live intact H. intuenzue type b 3068 or non-typable strain 12085 and incubated for 2 h at 4 "C. After three washes with PBS, the bacterial cells were suspended in a solution containing 251labelled anti-mouse immunoglobulins (Amersham) and incubated for 1 h at room temperature. The bacteria were washed twice with PBS and the amount of cell-bound 1251 was determined.
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Specificity of rnAbs for P2 protein
Culture supernatants of hybridomas obtained from fusion of primed spleen cells and SP2/0 myeloma cells were screened intitially by ELISA using outer membrane preparations from H. influenzae type b 3068, and nontypable H. influenzae JUST209 and 12085. In order to recover the hybridomas secreting P2-protein-specific mAbs, supernatants that were reactive with these preparations were retested with purified P2 protein from non-typable strain 12085. Several antibodies, all IgG K, were identified and were divided, based on their pattern of reactivity, into three groups which are represented by mAbs P2-17, P2-18 and P2-19.
The specificities of the mAbs were determined by immunoblotting using outer membrane preparations, purified P2 proteins and extracts from E. coli expressing or not expressing H. inflwmae P2 protein as antigens. Molecular mass heterogeneity among the P2 proteins of encapsulated and non-encapsulated strains was observed by SDS-PAGE analysis of outer membrane preparations ( Fig. 2a ). When tested by luminescent immunoblotting, all mAbs recognized epitopes present on a protein band with an approximate molecular mass of 40 kDa corresponding to the P2 protein (Fig. 26, c and d) . P2 proteins from all studied non-typable, type a, b and d strains were reactive with the mAbs with the exception of mAbs P2-17 and P2-19 which did not react with non-typable strain MTL6 and serotype a strain 541, respectively. mAbs also recognized their epitopes on purified and recombinant P2 proteins (Fig. 3) . None of the mAbs reacted with extracts of non-transformed E. coli JMlOl which were used as controls.
Reactivity of rnAbs against a panel of Haernophilus strains
ELISA and dot enzyme immunoassays were performed to determine the reactivity of mAbs against type a, b and d, and non-typable H. influenzae. Results obtained from this study are summarized in Table 1 . Each mAb had its own pattern of recognition. mAb P2-18 reacted with all strains while mAbs P2-17 and P2-19 missed 4 strains and 9 strains, respectively. Previous experiments with mAb P2-17 have suggested that isolates other than type b, including type a and d, and non-typable isolates, were not reactive with mAb P2-17 (Martin et al., 1990) . However, in the present study, immunoassays using outer membrane preparations and SDS-treated organisms instead of intact bacteria indicate that mAb P2-17 reacted with all capsulated and most non-typable H. influenzae strains. mAb P2-19 reacted with type a, b and On: Fri, 28 Dec 2018 16:37:34 d strains allied in division I whereas encapsulated strains allied in division 11, as well as some non-typable strains, were not recognized. None of the mAbs reacted with H . paraintfluenzae.
Specificity of mAbs to H . influenzae
Various Gram-negative species were tested with the mA bs, including Actinobacillus pleuropneumoniae, Enterobacter aerogenes, Edwardsiella tarda, Neisseria pertflava, Neisseria meningit idis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Shigella sonnei, Escherichia coli and Proteus vulgaris. Dot enzyme immunoassays using bacterial suspensions boiled in the presence or absence of SDS were negative with all strains, suggesting that only H. influenzae contained a protein reactive with the mA bs.
Cell surface accessibility of epitopes
To determine if our mAbs were directed against cellsurface-exposed epitopes, hybridoma culture supernatants were incubated with live bacteria. mAbs did not bind to live intact type b or non-typable H. influenzae as measured by radioimmunoassay indicating that the epitopes recognized by mAbs were not accessible on the cell surface. Furthermore, mAbs reacted very poorly in dot enzyme immunoassay using freshly prepared or multiple frozen and thawed bacterial suspensions. However, a positive response was always obtained using outer membrane preparations or bacteria boiled in the presence of SDS as antigens.
Localization of mAb-spec$c epitopes
Overlapping peptides covering the entire P2 protein sequence from H. influenzae MinnA were used in ELISA to map the epitopes recognized by the mAbs precisely. Fig. 4 shows the reactivities of mAbs with the synthetic peptides. mAbs P2-18, P2-17 and P2-19 reacted with peptide P1 (residues 1-14) , peptide 1 (residues 28-55) and peptide 4 (residues 101-129), respectively. An inhibition assay was performed to confirm the results obtained by direct ELISA. The amount of peptide required to inhibit 50% of the binding of the mAb to outer-membrane-coated plates was determined. The binding of mAbs to outer membrane preparations was inhibited specifically with the reactive peptide. The binding of mAb P2-18 was inhibited by concentrations of less than 0-2 p.g ml-l of peptide P1 (residues 1-14) . The binding of mAbs P2-17 and P2-19 was inhibited by 1-55 pg peptide 1 ml-l (residues 28-55) and 0-4p.g peptide 4 ml-l (residues 101-129), respectively. No inhibition was observed with control peptides. The absence of reactivity of the mAbs with peptide 10, which gave non-specific reaction with the conjugated antimouse immunoglobulins, was confirmed by peptide inhi bit ion assay.
Discussion
Outer membranes of Gram-negative bacteria must allow the influx of nutrients and efflux of waste products (Nikaido & Vaara, 1985) . A class of outer membrane proteins called porins is known to be involved in the non-specific transmembrane diffusion of solutes. So far, protein P2 is the only species of outer membrane proteins of H. injluenzae that has known porin activity (Vachon et al., 1985) . In this study, mAbs have been produced to investigate the antigenic and structural relationships among encapsulated and non-encapsulated H. inzuenzae P2 porin proteins. The reactivity spectrum of the mAbs was examined with a collection of carefully selected encapsulated and serologically non-typable isolates. These represented the major genetic clone families expressing serotype a, b and d capsules, and naturally occurring non-encapsulated organisms obtained from a variety of clinical conditions, in many geographic areas, including Islamabad in Pakistan where invasive diseaseproducing isolates were assigned to major clonal groups.
Our study demonstrates that the mAbs react with B-cell epitopes that are widely distributed among both encapsulated and non-encapsulated H. inJuenzae. The data obtained with mAb P2-18 clearly indicate that there are epitopes common to all strains of this pathogen. However, P2 proteins exhibit some antigenic heterogeneity among non-encapsulated isolates since the epitope defined by mAb P2-17 was present on all encapsulated strains but only on 78% of non-typable isolates. Recently, Musser et al. (1990) has demonstrated that the genetic structure of encapsulated H. influenzae is basically clonal, with divergent lineages divided in two deep phylogenetic divisions. In contrast, very extensive genetic diversity exists among non-typable isolates and, with few exceptions, none of the non-typable H . inyuenzae isolates shared the same clonal group (Musser et al., 1986; Porras et al., 1986) . In this context, the identification of epitopes shared by highly divergent encapsulated and non-encapsulated isolates was unpredictable. However, it was not surprising to notice that mAb P2-19 failed to react specifically with serotype a and b isolates assigned to division 11. This result was expected since division I1 is composed of clones rarely associated with invasive disease and highly divergent in overall chromosomal character from those clones in primary division I (Musser et al., 1988) . In addition, previous studies revealed that none of the 17 P2-specific mAbs reacted with genetically divergent serotype a or b clones assigned to primary division I1 (Hamel et al., 19876; Martin et al., 1990) . Although significant associations of clones with particular clinical syndromes or particular geographic areas have previously been reported , the lack of reactivity of mAbs P2-17 and P2-19 with some non-typable isolates could not be correlated to any known factors.
The native state of P2 protein in outer membranes and in purified form is most probably a trimer (Vachon et al., 1988) . These trimers are dissociated into monomers by treatment with ionic detergents such as SDS. Our mAbs reacted with both native and SDS-denatured P2 protein, suggesting that the mAbs were directed against sequence-continuous epitopes. Thus, it is possible that synthetic pept ides constituting these well-conserved epitopes might be reactive with our mAbs as long as the synthetic peptides cover all the critical residues. This study demonstrates that the highly conserved P2-18specific epitope is carried by the N-terminal segment (residues 1-14) whereas the epitopes reactive with P2-17 and P2-19 were located between residues 28 and 55, and 101 and 129, respectively. The lack of reactivity of mAb P2-17 and P2-19 with some isolates may be a consequence of nucleotide sequence variation occurring in the P2 protein structural gene.
All together, six distinct epitopes have been localized on the primary structure of H. injuenzae P2 proteins. In previous studies, we reported the identification of one conformational and two linear surface-exposed epitopes of P2 protein that were highly conserved among H. influenzae type b strains (Hamel et al., 1987a Martin et al., 1990 Martin et al., , 1991 . The linear epitopes were carried by the C-terminal end of the protein (residues 3 14-341) and residues 158-174, respectively. A segment of P2 protein (residues 148-174) in very close proximity to the surface of the bacteria carry a distinct internal epitope. In contrast to the epitopes described in the current study, these epitopes were only present on capsulated H. influenzae strains.
The location of the epitopes with respect to the membrane was studied in binding experiments performed with intact bacteria and outer membrane preparations. These studies clearly indicated that mA bs did not react with surface exposed epitopes. The positive reaction observed with membrane preparations might suggest that the epitopes recognized by mAbs constitute loops in the periplasm, since the membrane vesicles obtained from the extraction with lithium chloride are likely to be accessible from both sides. However, we cannot exclude the possibility that P2 proteins could have been dissociated during the outer membrane extraction procedure, allowing antibody to bind to epitopes normally embedded in the membrane.
Examining the amino acid sequences of porins from different H. influenzae type b strains reveals that the amino acid residues are fairly conserved (Munson et al. 1989a) . The low homology found between the sequences of P2 and other available porin proteins (Munson et al., 1989a) is in good agreement with the specificity of the mAbs to H. influenzae. Although the structural genes for the porins of non-serotype b isolates have not been determined, our data strongly suggest a very wellconserved structure of porin proteins. These observations are in accord with the highly conserved function of porin.
In summary, we have demonstrated that epitopes of native H. injhenzae P2 proteins are conserved among H . injluenzae P2 porin protein 167 different encapsulated and non-encapsulated isolates, as reported for porins of enterobacteriaceae (Klebba et al., 1990) . The outer membrane protein OmpF, a porin of E. coli, contains a conserved and internal region composed of residues which are involved in the determination of channel permeability properties. Immunochemical analyses of internal OmpF deletions which alter porin permeability indicated that these mutations cause internal structural changes that do not affect porin's surface epitopes. Whether the N-terminal portion of the P2 protein is critical to the structure of H . influenzae porins still remains to be determined. Our future studies will focus on identifying conserved epitopes on P2 protein that are accessible to antibodies in whole cells and that may be useful as vaccine components.
